Primary study · included by 1 review

Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.

Moller 2015 · Møller Eigild, Pedersen Søren Anker, Vinicoff Pablo Gustavo, et al. · Toxins · 2015

PubMed 26134257 doi:10.3390/toxins7072481Journal Article

Trial PICO

Not extracted yet. Trial-level population, intervention, comparator, outcomes and design will appear here after the trial extraction run. Until then, the reviews below describe the study.

Results

Not extracted yet. Per-trial results (events, means, effect and weight as each review's forest plot reports them) will appear here after the trial extraction run.

Included by

Oral health effects of botulinum toxin treatment for drooling: a systematic review.

Non-Cochrane · intervention · 2021 · cited as Moller 2015 · References [16]; Results (Carious lesions); Table 1 (open-label study)

Outcome this study informs	Pooled effect	Evidence	Certainty
New dental caries development Intraglandular botulinum neurotoxin (BoNT) injection vs No BoNT (placebo or pre-treatment baseline)	RR 2.4 [0.48, 11.80]	1 study	Ungraded
New dental caries development Intraglandular botulinum neurotoxin (BoNT) injection vs No BoNT (placebo or pre-treatment baseline)	RR 1.4 [0.24, 8.12]	1 study	Ungraded

1 including review in total.